← Back to Search

Terbinafine Tablets for Ankylosing Spondylitis (FUN Trial)

Phase < 1
Waitlist Available
Led By Atul Deodhar, M.D.
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

FUN Trial Summary

This trial will help researchers understand if a certain anti-fungal drug could help treat patients with a certain type of arthritis.

Eligible Conditions
  • Ankylosing Spondylitis
  • Spondylitis
  • Epidural Block
  • Psoriatic Spondylitis

FUN Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in BASDAI score

FUN Trial Design

2Treatment groups
Active Control
Group I: Drug to PlaceboActive Control2 Interventions
Subjects will begin treatment on study drug then crossover to placebo.
Group II: Placebo to DrugActive Control2 Interventions
Subjects will begin treatment on placebo then crossover to study drug.

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
979 Previous Clinical Trials
7,386,461 Total Patients Enrolled
The Malassezia FoundationUNKNOWN
Atul Deodhar, M.D.Principal InvestigatorOregon Health and Science University
~0 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top